{"id":4917,"date":"2022-08-19T12:40:11","date_gmt":"2022-08-19T12:40:11","guid":{"rendered":"https:\/\/pruefer.eu\/upc-updates\/"},"modified":"2025-09-03T13:01:07","modified_gmt":"2025-09-03T13:01:07","slug":"upc-updates","status":"publish","type":"page","link":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/","title":{"rendered":"UPC updates"},"content":{"rendered":"\n\n\n\n
\n
\n
\n \n
\n
\n \n \n \n <\/div>\n \n\n \n \n <\/div>\n \n \n <\/div>\n \n <\/div>\n <\/section>\n\n\n\n\n\n\n\n
\n
\n
\n \n

UPC updates<\/h1>\n
<\/div>\n

Latest news and important information<\/p>\n<\/div>\n \n\n <\/div>\n \n \n <\/div>\n<\/section>\n<\/polygon><\/svg>\n\n\n\n\n
\n \n
\n

\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
27. May 2025\n<\/div>\n

Dr Peter Klein has obtained the European Patent Litigation Certificate<\/h2>\n

We are delighted to announce that our partner Dr. Peter Klein has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law so that he is well prepared for representing clients in all proceedings before the Unified Patent Court.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
5. June 2024\n<\/div>\n

The UP-family starts growing! ROMANIA joins UPC<\/h2>\n

On 1 September 2024, ROMANIA will become the 18th member state of the UPC. The ratification of the Agreement on a Unified Patent Court (UPCA) was signed on 31 May 2024.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
8. May 2024\n<\/div>\n

Comment on UPC Court Decision of May 6, 2024<\/h2>\n

Before the Paris Local Division, in a case where the defendant had forced an intervener into the proceedings pursuant to Rule 316A RoP (forced intervention), the intervener has obtained a period of one month for filing its Application to Intervene as well as for filing its Statement in Intervention. Contrary to Rule 316.2 RoP, which mentions a “further period” for filing the Statement in Intervention, the Court did not set any such further period.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
19. March 2024\n<\/div>\n

Claim interpretation, burden of presentation and proof of facts from the UPC\u2019s perspective \u2013 UPC_CoA_335\/2023<\/h2>\n

The first decisions of the UPC have been handed down, and it will be exciting to learn the position of the UPC regarding the much-discussed issues of claim interpretation, the burden of presentation and proof for facts, and also regarding inventive step considerations.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
30. January 2024\n<\/div>\n

Comparison of opposition proceedings at the EPO andrevocation actions at the UPC \u2013 advantages and disadvantages<\/h2>\n

Since the introduction of the Unified Patent Court (UPC) in June 2023, a new system for central attacking the validity of and thereby to nullify a European Patent has been introduced. If a European patent of concern is an EU Unitary Patent, or if a classically validated European patent was not opted out from the competence of the UPC, a central revocation action under the UPC now exists in parallel to an opposition before the European Patent Office (EPO). Therefore, the question arises: what are the pros and cons of challenging the validity either before the EPO or before the UPC? The present report provides some guidance and discusses the main advantages and disadvantages of each system \u2013 which eventually is a matter of strategic considerations whether and which advantage may prevail \u2013 be it costs, timing, speed of proceedings, and possibly other issues.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
31. July 2023\n<\/div>\n

Dr Dorothea Hofer has obtained the European Patent Litigation Certificate<\/h2>\n

We are delighted to announce that our managing partner Dr. Dorothea Hofer has obtained the European Patent Litigation Certificate issued by the University of Maastricht in cooperation with the Academy of European Law (ERA) in Trier. This includes an extensive practical and theoretical training in the law underlying the Unified Patent Court (#UPC) and related fields of European law.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
27. July 2023\n<\/div>\n

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 3<\/h2>\n

Opposition proceedings before the European Patent Office (EPO) are an attractive forum for challenging patents; the procedure is virtually unrivaled worldwide in terms of value for money. The process is simple, streamlined and relatively inexpensive. The practice is well tested. However, there are restrictions and drawbacks \u2013 for example, a deadline of nine months after the grant date for submission, the long duration of the opposition and appeal proceedings, and strict rules for admitting evidence submitted late.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
27. July 2023\n<\/div>\n

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 2<\/h2>\n

During a seven-years transition phase, the jurisdiction of the future Unified Patent Court (UPC) can be declared inapplicable, by way of an opt-out request by the IP right holder, to a pending European patent application (“EP application”), to a granted European patent (“EP”), or to a supplementary protection certificate (“SPC”). This possibility was introduced to build confidence by users on the long run. If opted-out, disputes will then continue to be handled by national courts on a country-by-country basis. Once a European patent has been opted out, it is excluded from the jurisdiction of the UPC for its entire life.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
27. July 2023\n<\/div>\n

Chances and Risks of the New European Unitary Patentand New Unified Patent Court – Part 1<\/h2>\n

June 1, 2023 marks the beginning of a new era in European patent law: the new European Unitary Patent system entered into force, consisting of the Unitary Patent (UP) and the Unified Patent Court (UPC). 50 years after the introduction of the European Patent Convention and millions of European patents filed, this may be the most prominent change in European patent practice. The Unitary Patent adds as a third pillar to the classical European patents and the national patents. The Unified Patent Court will have an influence on both the unitary patent and the classical European patents as a modern and efficient litigation system.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n

\n
\n\t\t\t\n
\n
\n \n
<\/div> <\/div>\n
\n\n\n\n
\n
20. February 2023\n<\/div>\n

The Unified Patent Court will start on June 1, 2023<\/h2>\n

Years of planning finally become reality: The official starting signal has now been given! Germany ratified the Agreement on a Unified Patent Court (UPC) on February 17, 2023.<\/p>\n

To the article<\/span><\/p>\n <\/div>\n\n\n\n\n \n <\/div>\n <\/div>\n <\/a>\n <\/div>\n \n<\/section>\n\n\n\n\n \n\n\n \n \n<\/section>\n\n\n\n\n\n\n

\n
\n
\n \n

Your press contact<\/h2>\n
<\/div>\n \n\n <\/div>\n \n \n <\/div>\n<\/section>\n\n\n\n\n\n\n
\n
\n\n
\n
\n
\n
\n

Tamara Schantl<\/h3>\n

Manager Marketing & Business Development<\/p>\n

For national press topics<\/p>\n<\/p>\n Send an e-mail<\/a>\n<\/div>\n

\n\n\n<\/div>\n<\/div>\n<\/div> <\/div>\n
\n
\n
\n

Claire Zhou<\/h3>\n

Manager Marketing & Business Development<\/p>\n

For international press topics<\/p>\n<\/p>\n Send an e-mail<\/a>\n<\/div>\n

\n\n\n<\/div>\n<\/div>\n<\/div> <\/div>\n <\/div>\n <\/div>\n \n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":4996,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-4917","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nUPC updates - Pr\u00fcfer & Partner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UPC updates - Pr\u00fcfer & Partner\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/\" \/>\n<meta property=\"og:site_name\" content=\"Pr\u00fcfer & Partner\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-03T13:01:07+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/news-knowledge\\\/upc-updates\\\/\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/news-knowledge\\\/upc-updates\\\/\",\"name\":\"UPC updates - Pr\u00fcfer & Partner\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/#website\"},\"datePublished\":\"2022-08-19T12:40:11+00:00\",\"dateModified\":\"2025-09-03T13:01:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/news-knowledge\\\/upc-updates\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pruefer.eu\\\/en\\\/news-knowledge\\\/upc-updates\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/news-knowledge\\\/upc-updates\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\\\/knowledge\",\"item\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/news-knowledge\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"UPC updates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/\",\"name\":\"Pr\u00fcfer & Partner\",\"description\":\"Patentanwaltskanzlei f\u00fcr Pharma, Biotech, Life Sciences und Physik \u2013 M\u00fcnchen\",\"publisher\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/#organization\",\"name\":\"Pr\u00fcfer & Partner\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/pruefer.eu\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/logo.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Pr\u00fcfer & Partner\"},\"image\":{\"@id\":\"https:\\\/\\\/pruefer.eu\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UPC updates - Pr\u00fcfer & Partner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/","og_locale":"en_US","og_type":"article","og_title":"UPC updates - Pr\u00fcfer & Partner","og_url":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/","og_site_name":"Pr\u00fcfer & Partner","article_modified_time":"2025-09-03T13:01:07+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/","url":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/","name":"UPC updates - Pr\u00fcfer & Partner","isPartOf":{"@id":"https:\/\/pruefer.eu\/en\/#website"},"datePublished":"2022-08-19T12:40:11+00:00","dateModified":"2025-09-03T13:01:07+00:00","breadcrumb":{"@id":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pruefer.eu\/en\/news-knowledge\/upc-updates\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pruefer.eu\/en\/"},{"@type":"ListItem","position":2,"name":"News\/knowledge","item":"https:\/\/pruefer.eu\/en\/news-knowledge\/"},{"@type":"ListItem","position":3,"name":"UPC updates"}]},{"@type":"WebSite","@id":"https:\/\/pruefer.eu\/en\/#website","url":"https:\/\/pruefer.eu\/en\/","name":"Pr\u00fcfer & Partner","description":"Patentanwaltskanzlei f\u00fcr Pharma, Biotech, Life Sciences und Physik \u2013 M\u00fcnchen","publisher":{"@id":"https:\/\/pruefer.eu\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pruefer.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pruefer.eu\/en\/#organization","name":"Pr\u00fcfer & Partner","url":"https:\/\/pruefer.eu\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pruefer.eu\/en\/#\/schema\/logo\/image\/","url":"https:\/\/pruefer.eu\/wp-content\/uploads\/2022\/07\/logo.svg","contentUrl":"https:\/\/pruefer.eu\/wp-content\/uploads\/2022\/07\/logo.svg","width":"1024","height":"1024","caption":"Pr\u00fcfer & Partner"},"image":{"@id":"https:\/\/pruefer.eu\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/pages\/4917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/comments?post=4917"}],"version-history":[{"count":10,"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/pages\/4917\/revisions"}],"predecessor-version":[{"id":14463,"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/pages\/4917\/revisions\/14463"}],"up":[{"embeddable":true,"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/pages\/4996"}],"wp:attachment":[{"href":"https:\/\/pruefer.eu\/en\/wp-json\/wp\/v2\/media?parent=4917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}